Literature DB >> 12857108

Design and synthesis of a diverse morpholine template library.

Julia A H Lainton1, Mark C Allen, Matthew Burton, Stuart Cameron, Timothy R G Edwards, Grahame Harden, Rebecca Hogg, Wilson Leung, Steven Miller, Joseph J Morrish, Stuart M Rooke, Bernd Wendt.   

Abstract

Efficient and general procedures have been developed for the solution-phase preparation of substituted morpholine derivatives, and a library has been produced around generic structure 1. This library was designed with proprietary modeling software for use as a general screening library. The 30 R1 reagents were phenols, and the 275 R2 reagents were taken from five different reagent classes, giving a variety of product classes in the final library of 8250 potential products. All of the library members were generated from a common intermediate, mesylate (5), which was synthesized efficiently, in bulk, in three steps from N-benzylethanolamine (2). High-throughput chemistry using robotics was carried out to produce the 7907 library members, which were individually characterized by reversed-phase LC/MS analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857108     DOI: 10.1021/cc020052f

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  3 in total

1.  Balancing focused combinatorial libraries based on multiple GPCR ligands.

Authors:  Farhad Soltanshahi; Tamsin E Mansley; Sun Choi; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

2.  N-(2-Chloro-eth-yl)morpholine-4-carbox-amide.

Authors:  Oguejiofo T Ujam; Jonnie N Asegbeloyin; Brian K Nicholson; Pius O Ukoha; Nkechi N Ukwueze
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-03-22

3.  Synthesis and Initial Characterization of a Selective, Pseudo-irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer.

Authors:  Christian Gentzsch; Matthias Hoffmann; Yasuhiro Ohshima; Naoko Nose; Xinyu Chen; Takahiro Higuchi; Michael Decker
Journal:  ChemMedChem       Date:  2021-03-01       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.